Cargando…
The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
Constitutive activation of canonical WNT-TCF signaling is implicated in multiple diseases, including intestine and lung cancers, but there are no WNT-TCF antagonists in clinical use. We have performed a repositioning screen for WNT-TCF response blockers aiming to recapitulate the genetic blockade af...
Autores principales: | Melotti, Alice, Mas, Christophe, Kuciak, Monika, Lorente-Trigos, Aiala, Borges, Isabel, Ruiz i Altaba, Ariel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287931/ https://www.ncbi.nlm.nih.gov/pubmed/25143352 http://dx.doi.org/10.15252/emmm.201404084 |
Ejemplares similares
-
Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells
por: Seth, Chandan, et al.
Publicado: (2016) -
Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner
por: Kuciak, Monika, et al.
Publicado: (2019) -
A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12
por: Duquet, Arnaud, et al.
Publicado: (2014) -
A review on the effect of macrocyclic lactones on dung-dwelling insects: Toxicity of macrocyclic lactones to dung beetles
por: Jacobs, Carmen T., et al.
Publicado: (2015) -
Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas
por: Varnat, Frédéric, et al.
Publicado: (2010)